ArticleClinical nephrology. Case studies2025
Successful kidney transplantation in a patient with late-onset type II Bartter syndrome: A rare case report.
Article in Clinical nephrology. Case studies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bartter syndrome (BS) is a rare autosomal recessive disorder characterized by inherited salt-losing tubulopathies. Distinguished into six types, each associated with specific genetic mutations, type II is particularly rare in adults and typically presents early. This report documents a rare case of an adult diagnosed with type II Bartter syndrome that progressed to end-stage kidney disease (ESKD) and underwent successful kidney transplantation, marking it a first of its kind in India and only the second globally. The patient, diagnosed in adulthood, experienced a delayed onset of symptoms, including uremia, hypocalcemia, and medullary nephrocalcinosis, which progressed to ESKD. Genetic testing confirmed a homozygous missense mutation in the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.